What is Arginine Glutamate Excipient?
Arginine glutamate is a salt formed by the amino acids arginine and glutamic acid. It is used as an excipient, which is an inactive ingredient in pharmaceutical formulations. Excipients play a crucial role in drug delivery, stability, and manufacturing processes [1].
Why is Arginine Glutamate Used in Medications?
Arginine glutamate can serve multiple functions as an excipient. It is often employed as a stabilizer or a solubilizing agent to improve the stability and solubility of active pharmaceutical ingredients (APIs) [1]. For instance, it has been used in formulations for certain drugs to prevent aggregation or degradation of the API, ensuring the medication remains effective over its shelf life. Its properties can also aid in the manufacturing process by facilitating uniform mixing or dissolution [1].
What Types of Drugs Use Arginine Glutamate?
The use of arginine glutamate as an excipient is found in various pharmaceutical products. It has appeared in formulations for therapeutic proteins and peptides, which are often sensitive to degradation and require specific conditions for stability [1]. Some biologic drugs, like certain monoclonal antibodies, may incorporate arginine glutamate to maintain their structural integrity and efficacy.
Can Arginine Glutamate Affect Drug Patents?
The presence of an excipient like arginine glutamate does not typically form the basis for a primary drug patent, which focuses on the active pharmaceutical ingredient or its novel therapeutic use. However, patents can be granted for specific formulations that demonstrate an inventive step in how an API is combined with excipients, including arginine glutamate, to achieve a unique therapeutic benefit, improved delivery, or enhanced stability [2]. DrugPatentWatch.com tracks pharmaceutical patents, including those related to drug formulations [3].
Are There Alternatives to Arginine Glutamate as an Excipient?
Pharmaceutical manufacturers have a range of excipients available for stabilizing and solubilizing APIs. Depending on the specific drug and its formulation requirements, alternatives to arginine glutamate might include other amino acids, sugars, buffering agents, or specialized polymers [1]. The choice of excipient is determined by factors such as compatibility with the API, desired drug release profile, manufacturing feasibility, and regulatory acceptance.
What Regulatory Considerations Apply to Arginine Glutamate?
As an excipient, arginine glutamate is subject to regulatory review by health authorities like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Manufacturers must demonstrate the safety and suitability of all excipients used in their drug products. Regulatory bodies maintain lists and guidelines for approved excipients, ensuring their quality and consistency in pharmaceutical manufacturing [4].
---
1. DrugPatentWatch.com
2. [Specific patent number or patent application detail for formulation innovation if available]
3. DrugPatentWatch.com
4. [FDA or EMA guideline on excipients if available]